Clinical Trial Details

EORTC-40861

Back to Clinical Trials Database

Phase III double-blind clinical trial of an antiandrogen therapy versus a placebo in unresectable hepatocellular carcinoma

Study documentation

Trial Status All trial activities ended
Dates Date of activation: 15-Sep-1987
Date Step1 close: 13-Apr-1992
Data management at EORTC Yes
Design Phase 3
Randomized open label
Targeted Sample size EORTC Groups: 60
Treatment
Study Staff
Type of cancer
Participating groups
Protocol summary http://clinicaltrials.gov/study/
NCT number